Prosetta Bio-Conformatics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 02-01-2025
- Paid Up Capital ₹ 2.18 M
as on 02-01-2025
- Company Age 20 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 12.46%
(FY 2022)
- Profit 365.51%
(FY 2022)
- Ebitda 12.76%
(FY 2022)
- Net Worth 4.35%
(FY 2022)
- Total Assets 5.75%
(FY 2022)
About Prosetta Bio-Conformatics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.18 M, as per Ministry of Corporate Affairs (MCA) records.
Karl Manheim, Vishwanath Lingappa, Mahadevappa Prasad, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397KA2004PTC033501
- Company No.
033501
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Prosetta Bio-Conformatics?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishwanath Lingappa  | Director | 03-Mar-2004 | Current |
| Karl Manheim | Director | 03-Mar-2004 | Current |
Mahadevappa Prasad  | Director | 30-Jun-2007 | Current |
| Nisrani Ramakrishna | Director | 30-Jun-2007 | Current |
Financial Performance of Prosetta Bio-Conformatics.
Prosetta Bio-Conformatics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.46% increase. The company also saw a substantial improvement in profitability, with a 365.51% increase in profit. The company's net worth moved up by a moderate rise of 4.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prosetta Bio-Conformatics?
In 2023, Prosetta Bio-Conformatics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prosetta Bio-Conformatics?
Unlock and access historical data on people associated with Prosetta Bio-Conformatics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prosetta Bio-Conformatics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prosetta Bio-Conformatics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
